Thyroid ultrasound
Diagnostic TestPatients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound will undergo a second ultrasound using the Sound Blade Ultrasound.
NCT Number: NCT07488585
The objective of the THYMAL 01 pilot study is to evaluate the Sound Blade Imaging System in subjects with benign thyroid nodules undergoing standard-of-care ultrasound imaging.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound will undergo a second ultrasound using the Sound Blade Ultrasound.
Time frame: Day 1
The primary endpoint is to evaluate the ability to visualize thyroid nodules and other key anatomical structures with the investigational device compared to the SOC US imaging device.
Time frame: Day 1
A machine-learning model will be created to identify and segment thyroid nodules and key anatomical neck structures. The first outcome will evaluate performance of visibility and detection using standard classification measures
Time frame: Day 1
A machine-learning model will be created to identify and segment thyroid nodules and key anatomical neck structures. The second outcome will evaluate performance on delineable cases.
Contact information is provided by the study sponsor or research team.
Deborah Wright, Project Manager, RN
CONTACT
Richard Balys, MD, MD
CONTACT
Sound Blade Medical Inc.
Industry
A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning: A Pilot Study
Acronym: THYMAL 01
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06868459
Endocrine Gland Neoplasms, Endocrine System Diseases
Sarasota, Florida, United States
View Trial DetailsNCT00400465
Autoimmune Diseases, Endocrine Gland Neoplasms
Muang, Khonkaen, Thailand
View Trial DetailsNCT07340177
Endocrine Gland Neoplasms, Endocrine System Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT07226804
Endocrine Gland Neoplasms, Endocrine System Diseases
Houston, Texas, United States
View Trial Details